Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Not logged in
Back
Journal Details
Drug Design Development and Therapy
IF
5.1
Papers
501
Citations
15787
Related Insights
0
subscribe
Journal Papers
501
Related Insights
0
Journal Papers
501
Publication Date
Publication Date
IF
Citations
Mean Exposure Does Not Validate Target Attainment Predictions in Children [Response to Letter]
Drug Design Development and Therapy
IF
5.1
2026-09-30
0
OA
AI
Juan Wu
Share
Save
Median Effective Concentration of Ropivacaine for Ultrasound-Guided T
11
Thoracic Paravertebral Block in Patients with End-Stage Renal Disease: A Dixon Up-and-Down Dose-Finding Study
Drug Design Development and Therapy
IF
5.1
2026-09-29
0
OA
AI
Jinghui Ma; Jindi Cao; Xiangzhen Wang; Huanni Li; Wen Xu; Zejun Niu
Share
Save
Effects of Ciprofol- versus Remimazolam-Based Total Intravenous Anesthesia on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Randomized Controlled Trial
Drug Design Development and Therapy
IF
5.1
2026-09-28
0
OA
AI
Jinfang Zeng; Ying Ye; Zijian Li; Shu Yang; Jinjin Jian; Dongxiao Huang
Share
Save
Simultaneous Quantification of Vedolizumab, Ustekinumab, and Infliximab in Human Serum by LC-MS/MS: Application to Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Drug Design Development and Therapy
IF
5.1
2026-09-28
0
OA
AI
Yanbao Zhang; Na Wang; Weiyang Zheng; Ruichen Liu; Limei Li; Xianglong Zhao; Xin Zheng; Xiaohong Han
Share
Save
Leucine Mitigates Diabetic Nephropathy via Its Antioxidant Effect and Modulation of TGF-β/SMAD-3 Signalling Pathway in Streptozotocin-Induced Diabetic Rats
Drug Design Development and Therapy
IF
5.1
2026-09-28
0
OA
AI
Zekrayat JH Merdas; Mahmoud A Bekhit; Reem M Hazem; Enas S Gad; Nuseibah Al Qtaish; Alanoud F Alsumait; Norhan M El-Sayed
Share
Save
Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug–Polymer Interactions to in vivo Performance
Drug Design Development and Therapy
IF
5.1
2026-09-28
0
OA
AI
Sucilawaty Ridwan; Rimadani Pratiwi; Suci Zulaikha Hildayani; Arif Budiman
Share
Save
Integrated Multi-Omics, Machine Learning, and Single-Cell Analysis Provide Insights into Potential Multi-Target Candidate Mechanisms of Combined MAGL11 and Icaritin in Alleviating Imidazole Propionate-Driven Metabolic Intestinal Injury
Drug Design Development and Therapy
IF
5.1
2026-09-27
0
OA
AI
Rongrong Wang; Qingzhou Meng; Xishuang Wang; Mingmin Jiang; Dejun Niu; Guofei Qin; Qun Feng; Yujun Tan; Xu Jiao; Mengdi Zhang; Liyuan Gong; Wenlong Yang; Yunshun Qiu; Jingchun Yao; Shirong Li; Ming Liu
Share
Save
Liposomal Bupivacaine versus Bupivacaine Hydrochloride Plus Dexamethasone for Combined Adductor Canal and iPACK Blocks in Total Knee Arthroplasty: A Randomized Controlled Trial
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Pusheng Ren, Liang Zeng, Li Zhao, Longyi Zhang, Xin Zhou, Ying Xie
Share
Save
JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Zhi-Xian Wu; Wei-Zhen Tang; Hong-Yu Xu; Tong-Yu Chen; Zi-Han Lan; Yu-Han Yang; Run-Ning Liu; Ming-Si Li; Hao-Wen Chen; Tai-Hang Liu; Yong-Heng Wang
Share
Save
Initial Dosage Optimization of Tacrolimus in Connective Tissue Disease-Associated Interstitial Lung Disease Patients: An Exploratory Study
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Guan-Ying Zhang; Ying-Wei Jin; Jie Wang; Ke-Wen Ding; Shi-Yuan Zhao; Zhi-Hao Ping; Jia-Yi Du; Su-Mei He; Hai-Bo Zhang; Dong-Dong Wang
Share
Save
Comparative Protective Effects of ATP and TPP Against Olaparib-Induced Ovarian Injury in Rats: Insights from Biochemical Parameters, Histopathology, and IRE1α, Cleaved Caspase-3, LC3B, and NF-κB p65 Double Immunofluorescence
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Seyma Ilayda Paltaci; Nesrin Yilmaz; Sukran Kozali Uzun; Bulent Yavuzer; Taha Abdulkadir Coban; Mustafa Ozkaraca; Ali Gungor; Kamandar Yaqubov; Halis Suleyman
Share
Save
Statistical Concerns Regarding the Sample Size Justification in a Randomized Comparison of DPE and Standard Epidural PIEB Intervals for Labor Analgesia [Letter]
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Shaojin Bu; Fei Li
Share
Save
Mean Exposure Does Not Validate Target Attainment Predictions in Children: A Comment on the Study by Wu et al [Letter]
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Yue Yu
Share
Save
Analgesic Efficacy and Motor-Sparing Properties of Superior Trunk Block versus Interscalene Brachial Plexus Block with Liposomal Bupivacaine for Shoulder Arthroscopy: A Randomized Controlled Trial
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Mi Zhang; Zhe Jin; Mengyu Wang; Kai Tie; Yali Zhu; Jingcheng Wang; Zhen Li; Jianjuan Ke; Feng Zheng
Share
Save
Konjac Glucomannan as a Gel-Forming Biopolymer for Transdermal Drug Delivery: Properties, Formulation Strategies, and Translational Challenges
Drug Design Development and Therapy
IF
5.1
2026-09-26
0
OA
AI
Dian Arista Damayanti Asis; Yoga Windhu Wardhana; Anis Yohana Chaerunisaa
Share
Save
Bioequivalence Study of Two Formulations of Ibuprofen Arginine Granules in Healthy Chinese Adult Subjects
Drug Design Development and Therapy
IF
5.1
2026-09-25
0
OA
AI
Min Xu; Yu Chen; Xia Zhou; Jie Feng; Yingzi Wang; Peter Zeng; Marianna Armogida; Umesh Chandra Gupta; Hengqiu Liu; Billy Franks; Ying Jiang; Tracy Lu; Xiaojia Yang; Wen He
Share
Save
Combined Double-Filtration Plasmapheresis and Corticosteroids are Associated with Improved Outcomes in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: An Ambispective Multicenter Cohort Study
Drug Design Development and Therapy
IF
5.1
2026-09-24
0
OA
AI
Chunran Xue; Kan Wang; Lu Zhang; Jing Peng; Chong Xie; Desheng Zhu; Keyu Hao; Xia Li; Qiuju Li; Yong Hao; Yangtai Guan
Share
Save
Model-Informed Ceftazidime-Avibactam Dosing Stratified by Renal Function and Renal Replacement Therapy Status in Critically Ill Patients: A Prospective Population Pharmacokinetic and Monte Carlo Simulation Study
Drug Design Development and Therapy
IF
5.1
2026-09-23
0
OA
AI
Juan Hu; Chu-Hui Wang; Xiao-Juan Wang; Yong-Wei Yu; Jin-Ru Ji; Wei Zhu; Ping Shen; Yun-Bo Chen; Xia Zheng; Ting-ting Xiao; Hong-Liu Cai; Ya-Lin Dong; Yong-Hong Xiao
Share
Save
Advances of Peptide-Drug Conjugates in the Treatment of Digestive System Tumors
Drug Design Development and Therapy
IF
5.1
2026-09-23
0
OA
AI
Lu Yang; Min An; Jiahui Ma; Yangbing Li; Yaping Ma; Long Qin; Zhijian Han
Share
Save
Effective Dose 90 of Programmed Intermittent Epidural Bolus Volume at Three Ropivacaine Concentrations with Dural Puncture Epidural for Labor Analgesia: A Randomized Sequential Allocation Study
Drug Design Development and Therapy
IF
5.1
2026-09-23
0
OA
AI
Linsen Sun, Xiaojuan Ding, Peng Zhai, Yan Jiang, Meijuan Sun, Xiangsheng Xiong
Share
Save